Generic Ozempic Is Finally Here — And It's Changing Everything
For millions of Canadians who have been priced out of semaglutide — the active ingredient in Ozempic and Wegovy — the wait is over. Generic versions of the drug have begun landing on pharmacy shelves across the country, and the price drop is nothing short of dramatic.
Brand-name Ozempic has long carried a steep monthly cost that insurance plans don't always cover, putting it out of reach for many patients managing type 2 diabetes or obesity. Now, with generics arriving at select Rexall and Shoppers Drug Mart locations nationwide, that barrier is coming down fast.
What It Costs Now
Pharmacies are reporting that generic semaglutide is coming in at approximately $100 a month — a significant reduction compared to the brand-name version, which has historically run several hundred dollars per month without coverage.
That price point is being described by pharmacy staff and patients alike as a potential game-changer. For people who have been managing their conditions with lifestyle changes alone because they couldn't afford the medication, this opens a new door.
Demand Expected to Surge
Industry observers are already anticipating a spike in demand now that the generics are available. Semaglutide has been one of the most talked-about drug classes in recent memory, driven by its effectiveness for both blood sugar control in diabetic patients and meaningful weight loss for those with obesity.
The drug works by mimicking the GLP-1 hormone, which regulates appetite and insulin secretion. Clinical trials have shown it can help patients lose a significant percentage of their body weight over time, and its popularity has led to persistent supply shortages of the brand-name version in Canada and globally.
With generics now in the picture, supply chains are expected to be more robust — though initial rollout is still limited to certain pharmacy locations.
What This Means for Patients
For Canadians living with type 2 diabetes or obesity — conditions that affect millions — the arrival of affordable semaglutide could meaningfully change treatment conversations between patients and their doctors.
Previously, cost was often the deciding factor against prescribing the medication, even when it was clinically appropriate. At $100 a month, the calculus shifts. That said, patients should still speak with their pharmacist or physician before switching from a brand-name version or starting semaglutide for the first time, as dosing and formulations may vary slightly between products.
Availability Is Still Rolling Out
Not every pharmacy has stock yet. The rollout is happening in phases across the country, with Rexall and Shoppers Drug Mart among the first chains to carry the generic versions. Patients interested in accessing the lower-cost option are advised to call ahead and confirm availability at their local location.
As distribution expands and competition among generic manufacturers increases, prices could continue to fall over the coming months.
Source: CBC Health. This article is based on reporting from CBC News.
